Ivan Morgunov is an experienced entrepreneur driven by the goal of stopping aging. He founded Longaevus Technologies, a venture studio in the field of longevity, and <a target="_blank" href="https://unlimit.bio/">Unlimited Bio</a>—one of the two companies that administer genetic therapies in Prospera Dr. Anna Vakhrusheva has over a decade of experience in advancing vaccines and gene therapies. She led the development of Russia’s first recombinant SARS-CoV-2 vaccine (Betuvax JSC), driving it from R&D to clinical trials within two years. As a co-founder of Unlimited Bio, she spearheads genetic therapy research, translating cutting-edge science into real-world longevity solutions.In this episode, Anna & Ivan describe their journey to start a biotech company in Prospera, their novel thesis on why business model innovation matters to solve aging, the opportunity of “cocktail therapies”, regulatory fast-track options and challenges in a new jurisdiction.Explore Infinita City:* <a target="_blank" href="https://www.infinita.city/times">Explore the Archive: The Infinita City Times</a>* <a target="_blank" href="https://www.infinita.city">Visit Infinita City</a>* <a target="_blank" href="https://www.infinita.city/builders-hub">Join the Builders’ Hub on Telegram</a>* <a target="_blank" href="https://x.com/InfinitaCity">Follow Infinita City on X</a> This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://www.infinitacitytimes.com?utm_medium=podcast&#38;utm_campaign=CTA_1">www.infinitacitytimes.com</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Ep. 90: Unlimited Bio’s Journey to Launch a Prospera Biotech Company - with Ivan Morgunov & Dr. Anna Vakhrusheva

Stranded Technologies Podcast

AI Chapters

AI Insights

Reviews